Shareholder Alert: Ademi LLP Investigates Whether Titan Pharmaceuticals, Inc. Has Obtained a Fair Price for Its Public Shareholders
Shareholder Alert: Ademi LLP Investigates Whether Titan Pharmaceuticals, Inc. Has Obtained a Fair Price for Its Public Shareholders
MILWAUKEE, Aug. 23, 2024 /PRNewswire/ -- Ademi LLP is investigating Titan (NASDAQ: TTNP) for possible breaches of fiduciary duty and other violations of law in its transaction with KE Sdn. Bhd.
Ademi LLP正在调查Titan(纳斯达克:TTNP)与KE Sdn之间的交易是否存在可能违反法律的受托责任和其他违规行为。
Click here to learn how to join our investigation or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
点击这里了解如何加入我们的调查或拨打Guri Ademi的免费电话:866-264-3995。您不需要承担任何费用或义务。
Titan will engage in a reverse merger with KE and will become minority stockholders of the combined company. Dato' Seow Gim Shen, Chairman of the Board and Chief Executive Officer of Titan, is the holder of 47.4% of the outstanding shares of KE and non-insider Titan stockholders will own only 13% of the combined companies, post-merger. The transaction agreement unreasonably limits competing transactions for Titan by imposing a significant penalty if Titan accepts a competing bid. Titan insiders will receive substantial benefits as part of change of control arrangements.
Titan将与KE进行逆向合并,成为合并后公司的少数股东。Titan董事会主席兼首席执行官Dato' Seow Gim Shen是KE的47.4%持股人,非内部人士的Titan股东在合并后将仅拥有合并公司的13%。交易协议通过对Titan施加巨额罚款来不合理限制竞争交易。作为控制权变更安排的一部分,Titan内部人士将获得实质性的利益。
We are investigating the conduct of Titan's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
我们正在调查Titan董事会的行为,以确定他们是否履行了对所有股东的受托责任。
If you own Titan common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or .
如果您拥有Titan普通股并希望获取更多信息,请联系Guri Ademi,邮箱:[email protected],免费电话:866-264-3995。
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我们专门从事全国范围内有关收购、合并和个人股东权利的股东诉讼。欲了解更多信息,请随时与我们联系。律师广告。之前的业绩不保证类似的结果。
Contacts
联系方式
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
Ademi LLP
Guri Ademi
免费电话:(866) 264-3995
传真:(414) 482-8001
SOURCE Ademi LLP
信息来源:Ademi LLP